Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 52, Issue 15, Pages 4968-4972Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm900481c
Keywords
-
Categories
Funding
- Merckle/Ratiopharm Corporate Group, Blaubeuren, Germany
- Fonds der Chemischen Industrie, Germany
Ask authors/readers for more resources
We synthesized and evaluated inhibitors for the microsomal prostaglandin E-2 synthase-1 (mPGES-1), based on the arylpyrrolizine scaffold. In a cell free mPGES-1 assay several sulfonimides exceeded our lead ML3000 (3) in potency. The most promising compound, the tolylsulfonimide 11f, revealed an IC50 of 2.1 mu M and is equipotent to the literature reference molecule MK886 (1). Selected compounds also potently reduced 5-LOX product formation in intact cells. Inhibition of isolated COX was occasionally remarkably cut down.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available